Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38195
CAS Number:
29868-97-1
Dichlorhydrate de pirenzépine
Purity:
≥ 98 % (HPLC)
Synonym(s):
5,11-dihydro-11-[(4-méthyl-1-pipérazinyl)acétyl]-6 H -pyrido[2,3-b][1,4]benzodiazépin-6-onedichlorhydrate
Documents
$51.18 /200 mg
Taille
Request Bulk Quote
Informations sur le produit

Pirenzepine dihydrochloride is a potent muscarinic antagonist primarily utilized in the treatment of peptic ulcers and gastrointestinal disorders. This compound exhibits selective inhibition of the M1 muscarinic receptor, making it particularly effective in reducing gastric acid secretion and promoting mucosal healing. Its unique mechanism of action allows for targeted therapeutic effects, distinguishing it from other anticholinergic agents. Researchers and healthcare professionals appreciate Pirenzepine dihydrochloride for its ability to minimize side effects commonly associated with broader-spectrum anticholinergics, thus enhancing patient compliance.

In addition to its clinical applications, Pirenzepine dihydrochloride is also of interest in pharmacological research, particularly in studies exploring the role of muscarinic receptors in various physiological processes. Its potential use in treating conditions such as irritable bowel syndrome and other gastrointestinal motility disorders further underscores its versatility. With ongoing research, the compound holds promise for expanding its therapeutic applications, making it a valuable addition to any pharmaceutical portfolio.

Numéro CAS 
29868-97-1
Formule moléculaire
C19H21N5O2 · 2HCl
Poids moléculaire 
424.33
Point de fusion 
269 - 271 °C (déc.)
Informations générales
Numéro CAS 
29868-97-1
Formule moléculaire
C19H21N5O2 · 2HCl
Poids moléculaire 
424.33
Point de fusion 
269 - 271 °C (déc.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Pirenzepine dihydrochloride is widely utilized in research focused on:

  • Gastroenterology: This compound is primarily used to treat peptic ulcers by reducing gastric acid secretion, making it valuable in clinical settings for managing ulcer-related conditions.
  • Pharmacological Studies: Researchers employ pirenzepine to study its effects on muscarinic receptors, aiding in the development of new drugs targeting similar pathways in various diseases.
  • Neurological Research: Its role as a selective M1 muscarinic receptor antagonist allows scientists to explore potential treatments for cognitive disorders, including Alzheimer's disease.
  • Drug Development: The compound serves as a lead structure in medicinal chemistry, inspiring the design of novel therapeutics with improved efficacy and reduced side effects.
  • Clinical Trials: Pirenzepine is often included in trials to assess its effectiveness in combination therapies, providing insights into multi-drug regimens for gastrointestinal disorders.

Citations